Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- CheckyesterdayChange DetectedA new page revision marker (Revision: v3.5.5) was added and certain related topics entries (Multiple myeloma and MedlinePlus Genetics) were removed along with the older revision marker (Revision: v3.5.4). This update affects page metadata and topic labeling rather than the study details.SummaryDifference0.2%

- Check8 days agoChange DetectedAdded related topic references: Multiple myeloma and MedlinePlus Genetics, expanding access to background information on the condition and its genetics. The core study content remains unchanged.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision tag, v3.5.4, was added to the page, and several related topics entries (e.g., Multiple myeloma and MedlinePlus Genetics) were removed from the related topics/MeSH area, indicating metadata cleanup rather than a change to study information.SummaryDifference0.2%

- Check29 days agoChange DetectedAdded related-topic links for Multiple myeloma and MedlinePlus Genetics under the related topics section to connect the study page with disease-specific and genetic resources.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page's footer navigation references to related topics and MedlinePlus Genetics are removed. This reduces ancillary navigation text without altering the main study information.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov software/content revision label (v3.5.3 instead of v3.5.2). This represents a site/version update rather than a change to the study record content.SummaryDifference0.0%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.